{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T10:11:41Z","timestamp":1768903901281,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12883-018-1136-y","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T03:16:41Z","timestamp":1535685401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Hyperuricemia and dementia \u2013 a case-control study"],"prefix":"10.1186","volume":"18","author":[{"given":"Bettina","family":"Engel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willy","family":"Gomm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Broich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Weckbecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-6058","authenticated-orcid":false,"given":"Britta","family":"Haenisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"1136_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"Alzheimer's Association","year":"2016","unstructured":"Alzheimer's Association. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016;12:459\u2013509.","journal-title":"Alzheimers Dement"},{"key":"1136_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dc08-0272","volume":"32","author":"C Raffaitin","year":"2009","unstructured":"Raffaitin C, Gin H, Empana J-P, Helmer C, Berr C, Tzourio C, et al. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City study. Diabetes Care. 2009;32:169\u201374.","journal-title":"Diabetes Care"},{"key":"1136_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","volume":"15","author":"MD Mijajlovic","year":"2017","unstructured":"Mijajlovic MD, Pavlovic A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, et al. Post-stroke dementia - a comprehensive review. BMC Med. 2017;15:11.","journal-title":"BMC Med"},{"key":"1136_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/BOR.0b013e32835d951e","volume":"25","author":"C Li","year":"2013","unstructured":"Li C, Hsieh M-C, Chang S-J. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25:210\u20136.","journal-title":"Curr Opin Rheumatol"},{"key":"1136_CR5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/HJH.0000000000000701","volume":"33","author":"C Borghi","year":"2015","unstructured":"Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33:1729\u201341.","journal-title":"J Hypertens"},{"key":"1136_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","volume":"19","author":"GL Bowman","year":"2010","unstructured":"Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Uric acid as a CNS antioxidant. J Alzheimers Dis. 2010;19:1331\u20136.","journal-title":"J Alzheimers Dis"},{"key":"1136_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2174\/1871527314666150430161659","volume":"14","author":"E Mendez-Hernandez","year":"2015","unstructured":"Mendez-Hernandez E, Salas-Pacheco J, Ruano-Calderon L, T\u00e9llez-Valencia A, Cisneros-Mart\u00ednez J, Barraza-Salas M, et al. Lower uric acid linked with cognitive dysfunction in the elderly. CNS Neurol Disord Drug Targets. 2015;14:564\u20136.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1136_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/art.24193","volume":"59","author":"M De Vera","year":"2008","unstructured":"De Vera M, Rahman MM, Rankin J, Kopec J, Gao X, Choi H. Gout and the risk of Parkinson's disease: a cohort study. Arthritis Rheum. 2008;59:1549\u201354.","journal-title":"Arthritis Rheum"},{"key":"1136_CR9","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/01.wnl.0000279518.10072.df","volume":"69","author":"A Alonso","year":"2007","unstructured":"Alonso A, Rodr\u00edguez LA, Logroscino G, Hern\u00e1n MA. Gout and risk of Parkinson disease: a prospective study. Neurology. 2007;69:1696\u2013700.","journal-title":"Neurology"},{"key":"1136_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/aje\/kwm127","volume":"166","author":"MG Weisskopf","year":"2007","unstructured":"Weisskopf MG, O'Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson's disease. Am J Epidemiol. 2007;166:561\u20137.","journal-title":"Am J Epidemiol"},{"key":"1136_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamaneurol.2013.5528","volume":"71","author":"MA Schwarzschild","year":"2014","unstructured":"Parkinson Study Group SURE-PD Investigators, Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, et al. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014;71:141\u201350.","journal-title":"JAMA Neurol"},{"key":"1136_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/archneurol.2010.144","volume":"67","author":"EE Devore","year":"2010","unstructured":"Devore EE, Grodstein F, van Rooij FJ, Hofman A, Stampfer MJ, Witteman JC, et al. Dietary antioxidants and long-term risk of dementia. Arch Neurol. 2010;67:819\u201325.","journal-title":"Arch Neurol"},{"key":"1136_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00702-017-1743-6","volume":"124","author":"T Schirinzi","year":"2017","unstructured":"Schirinzi T, Di Lazzaro G, Colona VL, Imbriani P, Alwardat M, Sancesario GM, et al. Assessment of serum uric acid as risk factor for tauopathies. J Neural Transm. 2017;124:1105\u20138.","journal-title":"J Neural Transm"},{"key":"1136_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.exger.2017.01.002","volume":"89","author":"B Tuven","year":"2017","unstructured":"Tuven B, Soysal P, Unutmaz G, Kaya D, Isik AT. Uric acid may be protective against cognitive impairment in older adults, but only in those without cardiovascular risk factors. Exp Gerontol. 2017;89:15\u20139.","journal-title":"Exp Gerontol"},{"key":"1136_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11357-016-9871-8","volume":"38","author":"AA Khan","year":"2016","unstructured":"Khan AA, Quinn TJ, Hewitt J, Fan Y, Dawson J. Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age. 2016;38:16.","journal-title":"Age"},{"key":"1136_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/brain\/awn316","volume":"132","author":"SM Euser","year":"2009","unstructured":"Euser SM, Hofman A, Westendorp RG, Breteler MM. Serum uric acid and cognitive function and dementia. Brain. 2009;132:377\u201382.","journal-title":"Brain"},{"key":"1136_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/annrheumdis-2016-210767","volume":"77","author":"A Latourte","year":"2017","unstructured":"Latourte A, Soumar\u00e9 A, Bardin T, Perez-Ruiz F, Debette S, Richette P. Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study. Ann Rheum Dis. 2017;77:328\u201335.","journal-title":"Ann Rheum Dis"},{"key":"1136_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13075-015-0642-1","volume":"17","author":"JY Hong","year":"2015","unstructured":"Hong JY, Lan TY, Tang GJ, Tang CH, Chen TJ, Lin HY. Gout and the risk of dementia: a nationwide population-based cohort study. Arthritis Res Ther. 2015;17:139.","journal-title":"Arthritis Res Ther"},{"key":"1136_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/annrheumdis-2014-206917","volume":"75","author":"N Lu","year":"2016","unstructured":"Lu N, Dubreuil M, Zhang Y, Neogi T, Rai SK, Ascherio A, et al. Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study. Ann Rheum Dis. 2016;75:547\u201351.","journal-title":"Ann Rheum Dis"},{"key":"1136_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3233\/JAD-151006","volume":"54","author":"W Gomm","year":"2016","unstructured":"Gomm W, von Holt K, Thom\u00e9 F, Broich K, Maier W, Weckbecker K, et al. Regular benzodiazepine and Z-substance use and risk of dementia: an analysis of German claims data. J Alzheimers Dis. 2016;54:801\u20138.","journal-title":"J Alzheimers Dis"},{"key":"1136_CR21","first-page":"6929732","volume":"2018","author":"PH Chen","year":"2018","unstructured":"Chen PH, Cheng SJ, Lin HC, Lee CY, Chou CH. Risk factors for the progression of mild cognitive impairment in different types of neurodegenerative disorders. Behav Neurol. 2018;2018:6929732.","journal-title":"Behav Neurol"},{"key":"1136_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00207454.2013.821988","volume":"124","author":"A Fiolaki","year":"2014","unstructured":"Fiolaki A, Tsamis KI, Milionis HJ, Kyritsis AP, Kosmidou M, Giannopoulos S. Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease. Int J Neurosci. 2014;124:1\u201311.","journal-title":"Int J Neurosci"},{"key":"1136_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00103-007-0297-4","volume":"50","author":"K Giersiepen","year":"2007","unstructured":"Giersiepen K, Pohlabeln H, Egidi G, Pigeot I. Quality of diagnostic ICD coding for outpatients in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50:1028\u201338.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1136_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74:661\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1136_CR25","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00296-015-3284-3","volume":"35","author":"N Rashid","year":"2015","unstructured":"Rashid N, Levy GD, Wu YL, Zheng C, Koblick R, Cheetham TC. Patient and clinical characteristics associated with gout flares in an integrated healthcare system. Rheumatol Int. 2015;35:1799\u2013807.","journal-title":"Rheumatol Int"},{"key":"1136_CR26","first-page":"7","volume":"90","author":"B Engel","year":"2014","unstructured":"Engel B, Prautzsch H. Management of gout- new guidelines published by the German College of General Practitioners and Family Physicians (DEGAM). Z Allg Med. 2014;90:7\u201312.","journal-title":"Z Allg Med"},{"key":"1136_CR27","first-page":"215","volume":"114","author":"B Engel","year":"2017","unstructured":"Engel B, Just J, Bleckwenn M, Weckbecker K. Treatment options for gout. Dtsch Arztebl Int. 2017;114:215\u201322.","journal-title":"Dtsch Arztebl Int"},{"key":"1136_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semarthrit.2014.01.004","volume":"44","author":"CG Jennings","year":"2014","unstructured":"Jennings CG, Mackenzie IS, Flynn R, et al. Up-titration of allopurinol in patients with gout. Semin Arthritis Rheum. 2014;44:25\u201330.","journal-title":"Semin Arthritis Rheum"},{"key":"1136_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/RHU.0b013e3182314d40","volume":"17","author":"F Perez-Ruiz","year":"2011","unstructured":"Perez-Ruiz F, Carmona L, Y\u00e9benes MJ, Pascual E, de Miguel E, Ure\u00f1a I, et al. An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study. J Clin Rheumatol. 2011;17:349\u201355.","journal-title":"J Clin Rheumatol"},{"key":"1136_CR30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/ard.2008.092619","volume":"68","author":"JA Singh","year":"2009","unstructured":"Singh JA, Hodges JS, Asch SM. Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis. 2009;68:1265\u201370.","journal-title":"Ann Rheum Dis"},{"key":"1136_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/abbi.2000.1721","volume":"376","author":"GL Squadrito","year":"2000","unstructured":"Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, et al. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys. 2000;376:333\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"1136_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1600-0773.2003.pto930606.x","volume":"93","author":"S Muraoka","year":"2003","unstructured":"Muraoka S, Miura T. Inhibition by uric acid of free radicals that damage biological molecules. Pharmacol Toxicol. 2003;93:284\u20139.","journal-title":"Pharmacol Toxicol"},{"key":"1136_CR33","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1161\/01.ATV.0000027524.86752.02","volume":"22","author":"HU Hink","year":"2002","unstructured":"Hink HU, Santanam N, Dikalov S, McCann L, Nguyen AD, Parthasarathy S, et al. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol. 2002;22:1402\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1136_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1385\/NMM:3:2:65","volume":"3","author":"MP Mattson","year":"2003","unstructured":"Mattson MP. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. NeuroMolecular Med. 2003;3:65\u201394.","journal-title":"NeuroMolecular Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-018-1136-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:40:07Z","timestamp":1567230007000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-018-1136-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1186\/s12883-018-1136-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"9 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data access was legally approved by the Scientific Research Institute of the AOK (WIdO). The study is based on anonymised administrative claims data that never involved patients directly. Individual patients cannot be identified and the analyses presented do not affect patients whose anonymized records were used. Consent to participate: not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"131"}}